Brain potential evidence for an auditory sensory memory deficit in schizophrenia
1995/02/01 by Stanley V. Catts, A.M. Shelley, Philip B. Ward +4 · 27 citations
Neuroscience · Medicine · #Neuroscience and Music Perception #Schizophrenia research and treatment #Hallucinations in medical conditions
paper · doi:10.1176/ajp.152.2.213
Abstract
OBJECTIVE: The multiple disorders of selective attention found in schizophrenia could be secondary to disturbances in sensory processing. The authors investigated this possibility by using an event-related potential index of auditory sensory memory, called "mismatch negativity." METHOD: Medicated (N = 11) and neuroleptic-free (N = 11) patients with schizophrenia and patients with bipolar affective disorder (N = 11) were compared with age- and sex-matched healthy comparison subjects. Auditory stimuli were presented while the subjects were distracted with an attention-demanding visual task. Event-related potentials were elicited by infrequently occurring auditory stimuli (deviants) and by regularly presented auditory stimuli (standards), which differed slightly in duration. The difference in amplitude between the event-related potentials elicited by the deviant and standard stimuli was the mismatch negativity. RESULTS: The amplitude of the mismatch negativity was significantly lower in both groups of schizophrenic patients than in the healthy comparison subjects. Mismatch negativity amplitude was significantly correlated with ratings of negative schizophrenic symptoms but not with positive symptoms. Compared with the matched comparison subjects, the bipolar affective disorder patients did not show lower amplitude of mismatch negativity. There was a significant negative correlation between age and mismatch negativity amplitude. CONCLUSIONS: The abnormal auditory sensory memory processing indicated by low mismatch negativity amplitude in the schizophrenic patients cannot be accounted for by neuroleptic medication status. Because this abnormality was significantly related to measures of negative symptoms only, it may be a chronicity marker or reflect a predisposition to the development to schizophrenia. These findings implicate the auditory cortex in the pathophysiology of schizophrenia.
Cited by
- Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit
- Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
- Statistical parametric mapping of LORETA using high density EEG and individual MRI: application to mismatch negativities in schizophrenia. [europepmc]
- Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. [europepmc]
- Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. [europepmc]
- Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task. [europepmc]
- Mismatch negativity, social cognition, and functioning in schizophrenia patients. [europepmc]
- Electroencephalography (EEG) and event-related potentials (ERPs) with human participants. [europepmc]
- Oxidative stress in schizophrenia: an integrated approach. [europepmc]
- Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests. [europepmc]
- Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. [europepmc]
- Biomarkers of bipolar disorder: specific or shared with schizophrenia? [europepmc]
- Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. [europepmc]
- Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. [europepmc]
- Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. [europepmc]
- Mismatch negativity (MMN) as an index of cognitive dysfunction. [europepmc]
- Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle. [europepmc]
- Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. [europepmc]
- Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. [europepmc]
- Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. [europepmc]
- Electrophysiological Endophenotypes for Schizophrenia. [europepmc]
- Impairment in predictive processes during auditory mismatch negativity in ScZ: Evidence from event-related fields. [europepmc]
- Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia. [europepmc]
- Mismatch Negativity and Cortical Thickness in Patients With Schizophrenia and Bipolar Disorder. [europepmc]
- Electrophysiological evidence for abnormal glutamate-GABA association following psychosis onset. [europepmc]
- Neurophysiological Biomarkers in Schizophrenia-P50, Mismatch Negativity, and TMS-EMG and TMS-EEG. [europepmc]
- The Auditory Steady-State Response: Electrophysiological Index for Sensory Processing Dysfunction in Psychiatric Disorders. [europepmc]
Related